Announced Fri, 6 Nov, 2026 · 16:24 IST
Chief Scientific Officer Dr Preet Kaur resigns effective November 6, 2026
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
Dr. Preet Kaur resigned as Chief Scientific Officer and senior management member to pursue an opportunity outside the company. Her last working day and cessation date is November 6, 2026, although her resignation letter states October 8, 2026. She will complete the handover, and the company is identifying a replacement.
Likely market impact
Her departure creates a short-term gap in scientific leadership, though handover and replacement plans are underway. No financial impact was disclosed.